Tomorrow, Wednesday 5 November, the House of
Lords Public Services Committee will hear from two panels of
witnesses in evidence sessions which will explore the impact
medicines shortages have on primary and secondary care. The
sessions will also consider any incentives or support required to
ensure care providers and medicine distributors develop more
resilient systems.
The first session will focus on primary care and will
start at 11:00am while the second session will focus on secondary
care and start at 12.00pm. Both sessions can be watched live or
on demand at Parliament
TV or attend in person in Committee Room 3, Palace
of Westminster.
Giving evidence will be:
11:00am
-
Malcolm Harrison, Chief Executive, Company
Chemists' Association;
-
Martin Sawer, Healthcare Distribution
Association; and
-
, Director of
Research and Insights, Community Pharmacy England.
12:00pm
-
, former national
Director of Hospital Pharmacy for NHS England;
-
Amandeep Doll, Director for England, Royal
Pharmaceutical Society; and
-
Richard Bowers, Medicines Procurement and
Supply, Leeds Teaching Hospitals NHS Trust.
Questions will include:
- How resilient are existing supply chains?
- How effectively is information about medicine stocks,
shortages and potential communicated across the medicines supply
chain, and how might this be improved?
- What incentives and disincentives are there for pharmacists
and medicine distributors to maintain resilient supply chains,
and how might medicine supply in primary care be better
incentivised?
- What further support is needed in secondary care to
strengthen resilience to ensure medicines security?
- How big of an issue is waste of medications which are unused,
and could such medicines be put to better use?
- What recommendations should this Committee make to the
Government to better support secondary care service provision?
